{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:15:20Z","timestamp":1789467320182,"version":"build-2803163510"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100000683","name":"Royal Society of Tropical Medicine and Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["AIDS Care"],"DOI":"10.1080\/09540121.2026.2728918","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:44:56Z","timestamp":1789461896000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Genotype-guided antiretroviral therapy outcomes in routine clinical practice: a retrospective study of HIV viral load suppression at 6 and 12 months in Uganda"],"prefix":"10.1080","author":[{"given":"Collins","family":"Ankunda","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Makerere University","place":["Kampala, Uganda"]},{"name":"Department of Global Public Health, Karolinska Institute","place":["Stockholm, Sweden"]},{"name":"Mildmay Research Centre Uganda","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Emunyu","sequence":"additional","affiliation":[{"name":"Makerere University Walter Reed Program","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Namasambi","sequence":"additional","affiliation":[{"name":"Uganda Public Health Fellowship Program, Uganda National Institute of Public Health","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Sserunjogi","sequence":"additional","affiliation":[{"name":"Mildmay Research Centre Uganda","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendah","family":"Kyomuhangi","sequence":"additional","affiliation":[{"name":"Nursing and Midwifery, Entebbe Regional Referral Hospital","place":["Entebbe, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iving","family":"Mumbere","sequence":"additional","affiliation":[{"name":"School of Public Health, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nakawesi","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine Children\u2019s Foundation","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/1545109712463733","article-title":"Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings","volume":"12","author":"Adetunji A. A.","year":"2013","unstructured":"Adetunji, A. A. , Achenbach, C. , Feinglass, J., Darin, K. M., Scarsi, K. K., Ekong, E., Taiwo, B. O., Adewole, I. F., & Murphy, R. (2013). Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings. Journal of the International Association of Providers of AIDS Care , 12 , 236\u2013240.","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1186\/s12879-025-11607-w","article-title":"Prevalence of drug resistance mutations and their association with time to virological failure in people living with HIV in Uganda","volume":"25","author":"Ankunda C.","year":"2025","unstructured":"Ankunda, C. , Emunyu, J. , Namasambi, S. , Sserunjogi, C., Kyomuhangi, B., Mumbere, I., & Nakaweesi, J. (2025). Prevalence of drug resistance mutations and their association with time to virological failure in people living with HIV in Uganda. BMC Infectious Diseases , 25 , 1241.","journal-title":"BMC Infectious Diseases"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-026-26539-6"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1508793"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1751-0473-3-17","article-title":"Purposeful selection of variables in logistic regression","volume":"3","author":"Bursac Z.","year":"2008","unstructured":"Bursac, Z. , Gauss, C. H. , Williams, D. K. & Hosmer, D. W. (2008). Purposeful selection of variables in logistic regression. Source Code for Biology and Medicine , 3 , 17.","journal-title":"Source Code for Biology and Medicine"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAI.0000000000002321","article-title":"Viral rebound among persons with diagnosed HIV who achieved viral suppression, United States","volume":"84","author":"Craw J. A.","year":"2020","unstructured":"Craw, J. A. , Beer, L. , Tie, Y. Jaenicke, T., Shouse, R. L., & Prejean, J. (2020). Viral rebound among persons with diagnosed HIV who achieved viral suppression, United States. Journal of Acquired Immune Deficiency Syndromes , 84 , 133\u2013140.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15081732"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(17)30482-6"},{"key":"e_1_3_4_10_1","unstructured":"GPC . ( 2022 ). Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda November 2022 | GPC. Retrieved November 22 2024 from https:\/\/hivpreventioncoalition.unaids.org\/en\/resources\/consolidated-guidelines-prevention-and-treatment-hiv-and-aids-uganda-november-2022"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09161-y"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"000815.v3","DOI":"10.1099\/acmi.0.000815.v3","article-title":"HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline","volume":"6","author":"Kanyerezi S.","year":"2024","unstructured":"Kanyerezi, S. , Sserwadda, I. , Ssemaganda, A. Seruyange, J., Ayitewala, A., Oundo, H. R., Tenywa, W., Kagurusi, B. A., Tusabe, G., Were, S., Ssewanyana, I., Nabadda, S., Namaganda, M. M., & Mboowa, G. (2024). HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline. Access Microbiology , 6 , 000815.v3.","journal-title":"Access Microbiology"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874613601610010034","article-title":"HIV infection and AIDS in Sub-Saharan Africa: Current status, challenges and opportunities","volume":"10","author":"Kharsany A. B.","year":"2016","unstructured":"Kharsany, A. B. , & Karim, Q. A. ( 2016 ). HIV infection and AIDS in Sub-Saharan Africa: Current status, challenges and opportunities. The Open AIDS Journal , 10 , 34\u201348.","journal-title":"The Open AIDS Journal"},{"key":"e_1_3_4_14_1","volume-title":"Second-line ART after treatment failure or for regimen simplification\nSecond-line ART after treatment failure or for regimen simplification","author":"McGowan J.","year":"2025","unstructured":"McGowan, J. , Vail, R. , Shah, S. S. , Fine, S. M., Merrick, S. T., Radix, A. E., Rodrigues, J., Hoffmann, C. J., Norton, B. L., & Gonzalez, C. J. (2025). Second-line ART after treatment failure or for regimen simplification . Johns Hopkins University. Second-line ART after treatment failure or for regimen simplification http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589928\/"},{"key":"e_1_3_4_15_1","unstructured":"Mildmay Uganda . ( 2023 ). Empowering communities for healthier lives. Retrieved April 24 2023 from https:\/\/mildmay.or.ug\/"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305129"},{"key":"e_1_3_4_17_1","unstructured":"NIH . ( 2025 ). Optimizing ntiretroviral therapy in the setting of virologic suppression. NIH. Retrieved June 10 2025 from https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/optimizing-antiretroviral-therapy"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07453-9"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-021-00400-9"},{"key":"e_1_3_4_20_1","unstructured":"PMC . ( 2026 ). Prevalence of drug resistance mutations and their association with time to virological failure in people living with HIV in Uganda. PMC. Retrieved February 25 2026 from https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12502157\/"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013753"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12879-021-06162-z","article-title":"Predictive factors of viral load high-risk events for virological failure in HIV\/AIDS patients receiving long-term antiviral therapy","volume":"21","author":"Qin S.","year":"2021","unstructured":"Qin, S. , Lai, J. , Zhang, H. Wei, D., Lv, Q., Pan, X., Huang, L., Lan, K., Meng, Z., Liang, H., & Ning, C. (2021). Predictive factors of viral load high-risk events for virological failure in HIV\/AIDS patients receiving long-term antiviral therapy. BMC Infectious Diseases , 21 , 448.","journal-title":"BMC Infectious Diseases"},{"key":"e_1_3_4_23_1","unstructured":"The role of HIV viral suppression in improving individual health and reducing transmission . (2025). Retrieved June 10 2025 from https:\/\/www.who.int\/publications\/i\/item\/9789240055179"},{"key":"e_1_3_4_24_1","unstructured":"UNAIDS. (2022). | UNAIDS. Retrieved April 18 2022 from | UNAIDS. Retrieved April 18 2022 from https:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2022\/february\/20220207_hiv-variant"},{"key":"e_1_3_4_25_1","unstructured":"UNAIDS. (2025). | UNAIDS. Retrieved June 10 2025 from | UNAIDS. Retrieved June 10 2025 from https:\/\/www.unaids.org\/en\/resources\/presscentre\/pressreleaseandstatementarchive\/2023\/july\/unaids-global-aids-update"},{"key":"e_1_3_4_26_1","unstructured":"World Health Organization . (2024). Retrieved March 17 2024 from. Retrieved March 17 2024 from https:\/\/www.who.int\/publications-detail-redirect\/9789240031593"}],"container-title":["AIDS Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09540121.2026.2728918","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/09540121.2026.2728918","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09540121.2026.2728918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:45:06Z","timestamp":1789461906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09540121.2026.2728918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":25,"alternative-id":["10.1080\/09540121.2026.2728918"],"URL":"https:\/\/doi.org\/10.1080\/09540121.2026.2728918","relation":{},"ISSN":["0954-0121","1360-0451"],"issn-type":[{"value":"0954-0121","type":"print"},{"value":"1360-0451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=caic20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=caic20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}